Urgent FDA Help: Detained Shipments, Import Alerts & Lapsed Agents

When to use this playbook

Your shipment has been placed under FDA detention, held at the port, or marked for refusal of admission.
Your company, product, or facility appears on an FDA import alert, including detention without physical examination.
Your foreign facility registration is inactive, suspended, expired, or missing a valid U.S. Agent.
Your previous U.S. Agent stopped responding, withdrew, or failed to relay an FDA notice in time.
You need a U.S.-based point of contact who can help coordinate the immediate response across food, cosmetics, medical devices, or drugs.

In this situation, the goal is not to “become compliant eventually.” The goal is to stop the problem from widening: identify the exact FDA action, restore any broken registration or agent designation, and get the right documents in front of the right FDA system or office before a hold turns into a refusal. FDA’s import process gives importers a chance to respond to detention, but if FDA does not receive a response within the stated timeframe, refusal can follow. FDA detention and hearing guidance

What success looks like

You know whether the issue is a detention, refusal, import alert, prior notice problem, or registration defect.
A valid U.S. Agent is on file where required, and the facility or establishment record is updated in the correct FDA system.
The importer, broker, and manufacturer are working from the same facts and document set.
The FDA receives a timely, targeted response rather than a generic explanation.
You have a clear path either to release this shipment or to prevent the next one from being stopped for the same reason.

Fast triage: what problem are you actually dealing with?

Signal	What it usually means	Immediate priority	Common systems or records involved
Notice of FDA Action, detention notice, or port hold	FDA wants evidence, corrections, or clarification before release	Confirm deadline and submit the right response package	ITACS, entry documents, product records
Refusal of admission or refusal of entry	The response window was missed or the evidence was not enough	Determine whether reconditioning, export, destruction, or future-entry correction is the next path	Import entry file, refusal notice, broker records
Import alert / DWPE	FDA has enough evidence to detain future shipments without physical examination	Check the specific alert and removal pathway	Import Alert database
Registration inactive or no valid U.S. Agent	The facility or establishment record may be incomplete or noncompliant	Re-designate the agent and update the registration record fast	FURLS, DRLM, food registration, Cosmetics Direct, drug listing systems
Food shipment stopped before arrival or at arrival	Prior Notice may be missing, late, or incorrect	Correct the filing and align shipment details	PNSI / Prior Notice records

FDA import enforcement explains that import alerts support detention without physical examination, while the FDA import alert database is updated in real time.

Step-by-step crisis playbook

1. Freeze assumptions and collect the actual notice

Action: Get the exact FDA or broker notice, entry number, product description, manufacturer name, shipper, port, and date. Ask for screenshots if the message came through a broker portal rather than directly from FDA.

Expected outcome: You know whether you are dealing with detention, refusal, import alert exposure, prior notice failure, or a registration problem.

Gotchas: Teams often say “customs held it” when the operative issue is FDA, and they often say “registration problem” when the real trigger is product coding, labeling, or prior notice. Misreading the first notice wastes the most valuable hours.

Time estimate: 30–90 minutes if the broker is responsive.

2. Confirm the deadline before you build the response

Action: Identify the response window in the detention or hearing notice and confirm who is responsible for submitting documents. If the shipment is food, also confirm whether Prior Notice was filed correctly and on time.

Expected outcome: You know the clock you are working against and whether the next move is documentary, procedural, or both.

Gotchas: FDA states that if it does not receive a response to detention within the specified timeframe, the compliance officer can issue refusal of admission. For food, an invalid or missing Prior Notice can itself lead to a hold or refusal. FDA detention and hearing guidance; FDA Entry Point Prior Notice page

Time estimate: Same day.

3. Check whether your U.S. Agent is still valid and reachable

Action: Verify the U.S. Agent on file for the affected facility or establishment and confirm that the agent is still active, monitoring communications, and authorized to coordinate with FDA.

Expected outcome: You know whether the current problem is partly a communication failure.

Gotchas: A lapsed or nonresponsive U.S. Agent does not automatically explain every detention, but it often makes a bad situation worse because FDA notices, inspection coordination, and follow-up questions stop moving. FDA requires foreign device establishments to identify a U.S. Agent as part of registration, and foreign food facility registrations also require a U.S. Agent. FDA device U.S. Agent guidance; FDA foreign food facility Q&A

Time estimate: A few hours if you have account access; longer if the prior provider controls the login trail.

4. Re-designate the U.S. Agent in the correct FDA system

Action: Update the agent designation in the system that governs your vertical: food facility registration, device registration in FURLS/DRLM, cosmetics registration/listing, or the applicable drug establishment and listing workflow.

Expected outcome: FDA has a current U.S.-based contact tied to the affected foreign facility or establishment.

Gotchas: This is where companies lose time by treating all FDA-regulated products as if they use one shared workflow. Devices use FURLS/DRLM for registration and listing, and FDA’s device instructions are explicit that foreign establishments identify the U.S. Agent electronically there. Cosmetics and food have different registration paths and renewal cycles. FDA device registration instructions; FDA cosmetics registration and listing

Time estimate: Often same day to one business day once the right account access and facility details are available.

5. Repair the registration or listing defect, not just the contact record

Action: Check whether the facility registration, establishment registration, or product listing itself is inactive, expired, incomplete, or inconsistent with the shipment documents.

Expected outcome: You separate “agent problem” from “registration problem,” which are related but not identical.

Gotchas: A new U.S. Agent does not cure an expired registration by itself. Foreign drug establishments must register before offering drugs for import and renew annually; device establishments must keep registration and listing current; food and cosmetic records follow their own renewal cadence. FDA importing human drugs guidance; FDA registration and listing overview

Time estimate: Same day to several business days depending on the vertical and whether product-level listings also need correction.

6. Build the response package around the stated violation

Action: Match your documents to the reason FDA gave: registration proof, corrected listing data, label files, prior notice confirmation, product specifications, or other records requested in the notice.

Expected outcome: The response addresses the actual hold reason instead of flooding FDA with irrelevant attachments.

Gotchas: “More documents” is not the same as “better response.” If the issue is labeling, a registration receipt will not solve it. If the issue is prior notice, a general compliance letter will not solve it. For detained entries, FDA directs importers to upload documents through ITACS. FDA detention and hearing guidance

Time estimate: 4–24 hours for straightforward administrative defects; longer if labels, formulations, or listing data need revision.

7. Coordinate one message across manufacturer, importer, and broker

Action: Assign one owner for the response and make sure the broker, U.S. importer, and foreign manufacturer are using the same product names, codes, addresses, and registration identifiers.

Expected outcome: Fewer contradictory submissions and fewer avoidable follow-up questions.

Gotchas: The practical failure mode in urgent cases is not usually “nobody cared.” It is fragmented communication: the broker fixes the entry, the manufacturer updates a registration, and the agent answers a different question, all on separate timelines.

Time estimate: Same day if one person can force alignment quickly.

8. If an import alert is involved, separate shipment release from alert removal

Action: Look up the exact import alert and determine whether you are trying to clear one shipment, seek removal from detention without physical examination, or both.

Expected outcome: You avoid treating a systemic enforcement status like a one-off paperwork problem.

Gotchas: Import alerts are not generic warnings. FDA uses them when it has enough evidence or information to allow detention without physical examination, and the removal process can be more involved than fixing a single entry. FDA actions and enforcement

Time estimate: Same day to identify; much longer to resolve if the firm or product is on a red list.

9. Decide whether this shipment is salvageable or whether the real win is preventing the next failure

Action: Ask directly: can this entry still be released if the defect is corrected now, or has the matter moved to refusal, export, or destruction risk?

Expected outcome: You stop spending urgent money on a shipment that cannot realistically be saved and shift effort to reinstatement and future entries if needed.

Gotchas: Some teams stay emotionally attached to the current shipment when the better commercial decision is to fix the registration stack and relaunch the next entry cleanly.

Time estimate: Usually determinable within 1 business day once the notice and status are clear.

10. Put a live owner on renewals and FDA communications after the fire is out

Action: Once the immediate issue is stabilized, assign ongoing responsibility for renewal tracking, notice handling, and vertical-specific filings.

Expected outcome: The same lapse does not recur at the next renewal cycle or next shipment.

Gotchas: The cheapest U.S. Agent arrangement often works until the first real exception. FDA Entry Point presents its service as a human-liaison model rather than a mailbox-only designation, and states that it can confirm and submit registration updates within one business day for food U.S. Agent engagements. FDA Entry Point food U.S. Agent service

Time estimate: 1–5 business days to reset ownership and records properly.

What changes by vertical

Vertical	What often triggers the crisis	What usually needs checking first
Food & beverage	Prior Notice defects, food facility registration issues, inspection-related consequences, or import alert exposure	Prior Notice filing, facility registration status, U.S. Agent, importer and shipment details
Cosmetics	MoCRA confusion, facility registration or product listing gaps, labeling defects, Responsible Person vs. U.S. Agent mix-ups	Facility registration, product listing, label content, role assignments
Medical devices	FURLS/DRLM registration issues, listing mismatches, UDI/GUDID gaps, missing or stale U.S. Agent data	FURLS account access, establishment registration, listing, importer records
Drugs & pharma	Annual establishment renewal failures, listing defects, SPL-related issues, missing required registration before import	Establishment registration status, product listing status, submission records, importer alignment

Why response speed matters more than price in this moment

Urgent FDA problems compound quickly because the operational cost is not just the consulting fee. It is demurrage, missed launch windows, stockouts, distributor friction, and the risk that the next shipment repeats the same defect. That is why crisis buyers usually stop optimizing for the cheapest annual U.S. Agent and start optimizing for responsiveness, document control, and someone who can tell them which system actually needs fixing.

FDA Entry Point states that it offers same-day crisis response capability and positions its service as a human liaison for foreign manufacturers across food, cosmetics, devices, and drugs. That is a company claim rather than an FDA standard, but it maps to the real constraint in these cases: a passive mailbox is rarely enough once a shipment is already in trouble. FDA Entry Point practical guide

When this kind of service is and is not the right fix

Usually a fit: the problem is administrative, registration-related, prior-notice-related, or tied to a missing or failed U.S. Agent relationship.
Often still useful: the shipment issue spans multiple moving parts and you need one U.S.-based coordinator to align the manufacturer, broker, and FDA-facing response.
Not the whole answer: the core issue is a substantive product violation, adulteration, unsupported claim set, or a deeper quality-system problem. In those cases, a U.S. Agent or registration specialist may be necessary, but not sufficient.